Merial Introduces Next Generation Equine West Nile Virus Vaccine
Merial announced today the release of a new equine vaccine–RECOMBITEK Equine West Nile Virus (WNV) vaccine. The recent USDA approval of RECOMBITEK Equine West Nile Virus vaccine offers veterinarians a first-of-its-kind product backed by cutting-edge science to offer fast-acting and long-lasting protection from the often deadly WNV. (Click <A
- Topics: Article
Merial announced today the release of a new equine vaccine–RECOMBITEK Equine West Nile Virus (WNV) vaccine. The recent USDA approval of RECOMBITEK Equine West Nile Virus vaccine offers veterinarians a first-of-its-kind product backed by cutting-edge science to offer fast-acting and long-lasting protection from the often deadly WNV. (Click here for an earlier article on the vaccine.)
“The RECOMBITEK West Nile Virus vaccine uses recombinant DNA technology to stimulate a fast, multifaceted and long-lasting immune response proven by natural mosquito challenge of West Nile virus,” says Mike Murray, DVM, MS, Merial Equine Technical Director for Strategic Development. “The fast-acting immune response was demonstrated in a controlled trial that showed horses were protected from viremia caused by West Nile virus infection when challenged as early as two weeks after completion of the two-vaccination series
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Written by:
Press Release
Related Articles
Stay on top of the most recent Horse Health news with
